Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | IDH1 | O75874 | 1/20 | 0.41 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6586984 | 0.97 | CALM1 (0.52) | CALM1LTA4HPOLBIDH1PLA2G10 | |
| SCHEMBL2051544 | 0.97 | CALM1 (0.52) | CALM1LTA4HPOLBIDH1PLA2G10 | |
| SCHEMBL1829180 | 0.97 | CALM1 (0.52) | CALM1LTA4HPOLBIDH1PLA2G10 | |
| SCHEMBL1829354 | 0.95 | CALM1 (0.55) | CALM1LTA4H | |
| SCHEMBL2973782 | 0.89 | CALM1 (0.61) | CALM1LTA4HIDH1LMNA | |
| SCHEMBL10822020 | 0.80 | CALM1 (0.50) | CALM1LTA4HIDH1LMNA | |
| SCHEMBL6604926 | 0.78 | HTR2C (0.50) | CALM1LMNAHRH1 | |
| SCHEMBL28384985 | 0.78 | GBA1 (0.50) | — | |
| Diphenylmethane SCHEMBL28085719 | 0.77 | CALM1 (0.80) | CALM1LTA4HIDH1PLA2G10PLA2G2A | |
| Diphenylmethane SCHEMBL28072604 | 0.77 | CALM1 (0.80) | CALM1LTA4HIDH1PLA2G10PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903091-A | Aromatic amine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| WO-2024061366-A1 | SMALL MOLECULE COMPOUND HAVING PHOSPHORYLATED ARYL STRUCTURE, AND USE THEREOF | 杭州天玑济世生物科技有限公司 | 2024-03-28 | — | — | WO | claimed |
| CN-117750798-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117651433-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117603249-A | Triarylamine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-113423709-B | Triazinone imidazole compound and medical application thereof | 四川科伦博泰生物医药股份有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-117377338-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-117209524-A | Heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-117126190-A | Triarylamine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-117105795-A | Aromatic amine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116082322-A | Heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-116063261-A | Triamine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-113423709-A | Triazinoneimidazoles and their use in medicine | 四川科伦博泰生物医药股份有限公司 | 2021-09-21 | — | — | CN | claimed |
| WO-2020207352-A1 | TRIAZINE BENZIMIDAZOLE COMPOUNDS AND MEDICAL USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2020-10-15 | — | — | WO | claimed |
| CN-103860538-A | Lead compound of targeted human La protein and use of lead compound in preparation of medicine for preventing hepatitis B virus | SHANGHAI 1ST PEOPLES HOSPITAL | 2014-06-18 | — | — | CN | claimed |
| CN-102690262-A | Lead compound of targeted human La protein and application thereof in preparation of anti-hepatitis B virus medicine | SHANGHAI 1ST PEOPLES HOSPITAL | 2012-09-26 | — | — | CN | claimed |
| US-7282512-B2 | Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 2007-10-16 | — | — | US | claimed |
| US-20050054819-A1 | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors | SMITHKLINE BEECHAM CORPORATION | 2005-03-10 | — | — | US | claimed |
| US-4211867-A | ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS | MCNEIL LABORATORIES, INCORPORATED (US) | 1980-07-08 | — | — | US | claimed |
| US-4061746-A | Lactamimide inhibitors of gastrointestinal hypersecretion | RICHARDSON-MERRELL INC. (US) | 1977-12-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054819-A1 | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors | CTSK, CTSS, CTSE | CALM1 2917/4885LTA4H 195/4885POLB 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.